Search Results 1071-1080 of 16104 for pharmacogenetics

1. Addressing Diabetes Together - Mayo Clinic

   About this study. Integration of Diabetes Prevention Program (DPP) and Diabetes Self Management Program (DSMP) into WellConnect.

2. A Study to Evaluate Thalamic Stimulation to Prevent Impaired Consciousness in Epilepsy - Mayo Clinic

   The purpose of this study is to investigate the feasibility and safety of thalamic CL stimulation in restoring consciousness in epilepsy patients. Participation ...

3. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders - Mayo Clinic

   About this study. The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic ...

4. Transplant Organ Genomics to Help Prevent Rejection in Kidney Transplant Recipients – RNA-seq Signature Validation - Mayo Clinic

   About this study. The purpose of this study is to validate the use of an RNA-seq based peripheral blood assay in renal transplant recipients in adult kidney ...

5. A Study to Confirm the Effectiveness and Safety of Terlipressin for Treatment of Hepatorenal Syndrome Type 1 - Mayo Clinic

   The purpose of this study is to confirm the effectiveness and safety of terlipressin in the treatment of adult patients with hepatorenal syndrome (HRS) type 1.

6. A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) - Mayo Clinic

   About this study. This is a study of TRC105 in combination with standard dose pazopanib compared to single agent pazopanib in patients with angiosarcoma not ...

7. A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients - Mayo Clinic

   Cabozantinib and sunitinib are both FDA approved and commercially available for the treatment of advanced kidney cancer, including vhRCC. Participation ...

8. Philip T. Hagen, M.D. - Doctors and Medical Staff - Mayo Clinic

   Education · 1988. ResidentPreventive Medicine, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine · 1987. Fellow - ...

9. A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma - Mayo Clinic

   About this study. The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary effectiveness of AZD0466 as ...

10. Faculty - Division of Endocrinology, Diabetes, Metabolism, and Nutrition-Research - Mayo Clinic Research

    An expert faculty guides research in the Mayo Clinic Division of Endocrinology, Diabetes, Metabolism, and Nutrition.